In 2025, Aetna will merge its three stand-alone prescription drug plans into a single plan and member cost-shares will be ...

Reference ustekinumab was originally approved by the FDA in 2009. Wezlana (ustekinumab-auub) was approved last October.

With this year's Breast Cancer Awareness Month now underway, we are sharing eight facts and updates about breast cancer that ...

Blue Shield of California is purchasing Idacio for a net price of $525 per monthly dose, and most plan member will pay $0 out ...

VX-880 is an allogeneic stem cell-derived islet cell therapy that has been able to control blood glucose as well as natural ...